ThePharmaLetter.com: "Another Big Pharma in Show of Faith in Big Data"

US pharma giant Merck & Co, led investment in USA-based start-up Antidote

We're thrilled to be a part of the movement towards big data improving medical research, and are honored to have received funding from Merck. ThePharmaLetter.com covered the news: 

"German life sciences company Merck KGaA (MRK: DE) on Sunday became the latest pharma major to back the big data revolution that some believe will transform healthcare."

Read more at ThePharmaLetter.com

By
Lisa Brockway
On
September 23, 2026

© 2026 Antidote Technologies, Inc.